Tiverton Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-196
Closed -$313K 476
2018
Q1
$313K Buy
+196
New +$313K 0.02% 262